| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Javier Rampolla last filed a Form 4 in February 2025, as Chief Financial Officer at SRTS. Javier Rampolla's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 40,745 shares of SRTS. The SRTS filings lean toward selling, a net 8,499 shares.
Javier Rampolla has 9 Form 4 filings on record from June 2020 to February 2025, all as Chief Financial Officer at Sensus Healthcare (SRTS), 2020–2025.
The 12 reported transactions were 8 tax withholdings, 1 open-market purchase, 1 option exercise and 1 open-market sale, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $3K and 1 sale worth about $85K.
The only open-market purchase was 501 shares of SRTS at an average $5.95 on February 10, 2025, about $3K. Twelve months later SRTS was down 19%.
The only open-market sale was 9,000 shares of SRTS at an average $9.42 on March 4, 2022, about $85K. Twelve months later SRTS was down 32%.
Shares as reported in the last Form 4 for each company; the most recent is from February 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.